| Zydus Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532321 |
NSE Symbol : ZYDUSLIFE |
P/E(TTM) : 31.22 |
|
ISIN Demat : INE010B01027 |
Div & Yield% : 0.09 |
EPS(TTM) : 36.54 |
|
Book Value(₹) : 237.30 |
Market Cap(₹Cr) : 113,790.25 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,723.50 | 3,564.60 | 2,207.20 | 2,808.80 | 2,495.80 | 5,633.50 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,723.50 | 3,564.60 | 2,207.20 | 2,808.80 | 2,495.80 | 5,633.50 |
| Other Operating Income | 148.70 | 176.30 | 76.40 | 62.40 | 92.50 | 186.10 |
| Other Income | 123.70 | 495.10 | 473.80 | 541.50 | 157.10 | 185.40 |
| Total Income | 2,995.90 | 4,236.00 | 2,757.40 | 3,412.70 | 2,745.40 | 6,005.00 |
| Total Expenditure | 2,285.20 | 1,858.60 | 2,144.70 | 1,719.30 | 2,002.90 | 2,046.90 |
| PBIDT | 710.70 | 2,377.40 | 612.70 | 1,693.40 | 742.50 | 3,958.10 |
| Interest | 103.10 | 115.50 | 116.00 | 113.80 | 137.60 | 155.40 |
| PBDT | 607.60 | 2,261.90 | 496.70 | 1,579.60 | 604.90 | 3,802.70 |
| Depreciation | 151.90 | 150.90 | 144.30 | 136.00 | 130.00 | 128.00 |
| Tax | 117.70 | 446.70 | 81.80 | 281.70 | 89.60 | 826.50 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.60 | -57.70 | -25.90 | 5.30 | 0.60 | 34.50 |
| Reported Profit After Tax | 339.60 | 1,722.00 | 296.50 | 1,156.60 | 384.70 | 2,813.70 |
| Extra-ordinary Items | 0.00 | -84.20 | -46.15 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 339.60 | 1,806.20 | 342.65 | 1,156.60 | 384.70 | 2,813.70 |
| EPS (Unit Curr.) | 3.38 | 17.11 | 2.95 | 11.49 | 3.82 | 27.96 |
| EPS (Adj) (Unit Curr.) | 3.38 | 17.11 | 2.95 | 11.49 | 3.82 | 27.96 |
| Calculated EPS (Unit Curr.) | 3.40 | 17.12 | 2.95 | 11.50 | 3.82 | 27.97 |
| Calculated EPS (Adj) (Unit Curr.) | 3.40 | 17.12 | 2.95 | 11.50 | 3.82 | 27.97 |
| Calculated EPS (Ann.) (Unit Curr.) | 13.61 | 68.47 | 11.79 | 45.99 | 15.30 | 111.88 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 13.61 | 68.47 | 11.79 | 45.99 | 15.30 | 111.88 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 99.80 | 100.60 | 100.60 | 100.60 | 100.60 | 100.60 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 26.10 | 66.69 | 27.76 | 60.29 | 29.75 | 70.26 |
| PBDTM(%) | 22.31 | 63.45 | 22.50 | 56.24 | 24.24 | 67.50 |
| PATM(%) | 12.47 | 48.31 | 13.43 | 41.18 | 15.41 | 49.95 |
